New Advances in Chemical Research, May 2021. Synthetic Route of 2682-49-7, Chemical engineers ensure the efficiency and safety of chemical processes, adapt the chemical make-up of products to meet environmental or economic needs, and apply new technologies to improve existing processes. In a document type is Review, and a compound is mentioned, 2682-49-7, Thiazolidin-2-one, introducing its new discovery.
Cancer, still in the limelight due to its dreadful nature, shows overexpression of multiple signaling macromolecules leading to failure of many chemotherapeutic agents and acquired resistance to chemotherapy. These factors highlight the significance of shifting toward targeted therapy in cancer research. Recently, ERKs (ERK1 and 2) have been established as a promising target for the management of various types of solid tumors, due to their aberrant involvement in cell growth and progression. Several ERKs inhibitors have reached clinical trials for the management of cancer and their derivatives are being continuously reported with noteworthy anticancer effect. This review highlights the recent reports on various chemical classes involved in the development of ERKs inhibitors along with their in vitro and in vivo activity and structure-activity relationship profile.
You can get involved in discussing the latest developments in this exciting area about Synthetic Route of 2682-49-7, you can also check out more blogs about2682-49-7
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H407N | ChemSpider